These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23927048)

  • 21. Insight into conformational modification of alpha-synuclein in the presence of neuronal whole cells and of their isolated membranes.
    Smaldone G; Diana D; Pollegioni L; Di Gaetano S; Fattorusso R; Pedone E
    FEBS Lett; 2015 Mar; 589(7):798-804. PubMed ID: 25701590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformational properties of the SDS-bound state of alpha-synuclein probed by limited proteolysis: unexpected rigidity of the acidic C-terminal tail.
    de Laureto PP; Tosatto L; Frare E; Marin O; Uversky VN; Fontana A
    Biochemistry; 2006 Sep; 45(38):11523-31. PubMed ID: 16981712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synuclein.
    Smith DP; Tew DJ; Hill AF; Bottomley SP; Masters CL; Barnham KJ; Cappai R
    Biochemistry; 2008 Feb; 47(5):1425-34. PubMed ID: 18179253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo cross-linking reveals principally oligomeric forms of α-synuclein and β-synuclein in neurons and non-neural cells.
    Dettmer U; Newman AJ; Luth ES; Bartels T; Selkoe D
    J Biol Chem; 2013 Mar; 288(9):6371-85. PubMed ID: 23319586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acceleration of alpha-synuclein aggregation by homologous peptides.
    Du HN; Li HT; Zhang F; Lin XJ; Shi JH; Shi YH; Ji LN; Hu J; Lin DH; Hu HY
    FEBS Lett; 2006 Jun; 580(15):3657-64. PubMed ID: 16764865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UV-induced selective oxidation of Met5 to Met-sulfoxide leads to the formation of neurotoxic fibril-incompetent α-synuclein oligomers.
    Carmo-Gonçalves P; Pinheiro AS; Romão L; Cortines J; Follmer C
    Amyloid; 2014 Sep; 21(3):163-74. PubMed ID: 24784227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.
    Jo E; Fuller N; Rand RP; St George-Hyslop P; Fraser PE
    J Mol Biol; 2002 Jan; 315(4):799-807. PubMed ID: 11812148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction with synphilin-1 promotes inclusion formation of alpha-synuclein: mechanistic insights and pathological implication.
    Xie YY; Zhou CJ; Zhou ZR; Hong J; Che MX; Fu QS; Song AX; Lin DH; Hu HY
    FASEB J; 2010 Jan; 24(1):196-205. PubMed ID: 19762560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of nitration on the structure and aggregation of alpha-synuclein.
    Uversky VN; Yamin G; Munishkina LA; Karymov MA; Millett IS; Doniach S; Lyubchenko YL; Fink AL
    Brain Res Mol Brain Res; 2005 Mar; 134(1):84-102. PubMed ID: 15790533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The conformation and the aggregation kinetics of α-synuclein depend on the proline residues in its C-terminal region.
    Meuvis J; Gerard M; Desender L; Baekelandt V; Engelborghs Y
    Biochemistry; 2010 Nov; 49(43):9345-52. PubMed ID: 20828147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methamphetamine binds to α-synuclein and causes a conformational change which can be detected by nanopore analysis.
    Tavassoly O; Lee JS
    FEBS Lett; 2012 Sep; 586(19):3222-8. PubMed ID: 22771474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.
    Mishizen-Eberz AJ; Norris EH; Giasson BI; Hodara R; Ischiropoulos H; Lee VM; Trojanowski JQ; Lynch DR
    Biochemistry; 2005 May; 44(21):7818-29. PubMed ID: 15909996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of recombinant tetrameric N-acetylated α-synuclein.
    Fernández RD; Lucas HR
    Protein Expr Purif; 2018 Dec; 152():146-154. PubMed ID: 30041032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One single method to produce native and Tat-fused recombinant human α-synuclein in Escherichia coli.
    Caldinelli L; Albani D; Pollegioni L
    BMC Biotechnol; 2013 Apr; 13():32. PubMed ID: 23557146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heat-mediated enrichment of α-synuclein from cells and tissue for assessing post-translational modifications.
    Vicente Miranda H; Xiang W; de Oliveira RM; Simões T; Pimentel J; Klucken J; Penque D; Outeiro TF
    J Neurochem; 2013 Sep; 126(5):673-84. PubMed ID: 23534813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temperature-dependent structural changes of Parkinson's alpha-synuclein reveal the role of pre-existing oligomers in alpha-synuclein fibrillization.
    Ariesandi W; Chang CF; Chen TE; Chen YR
    PLoS One; 2013; 8(1):e53487. PubMed ID: 23349712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macromolecular and Small Molecular Crowding Have Similar Effects on α-Synuclein Structure.
    Bai J; Liu M; Pielak GJ; Li C
    Chemphyschem; 2017 Jan; 18(1):55-58. PubMed ID: 27860069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of wild-type α-synuclein binding and orientation on gold nanoparticles.
    Yang JA; Johnson BJ; Wu S; Woods WS; George JM; Murphy CJ
    Langmuir; 2013 Apr; 29(14):4603-15. PubMed ID: 23477540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assays for α-synuclein aggregation.
    Giehm L; Lorenzen N; Otzen DE
    Methods; 2011 Mar; 53(3):295-305. PubMed ID: 21163351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease.
    Angot E; Brundin P
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S143-7. PubMed ID: 20082977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.